Literature DB >> 28388509

Nodular lesions in diabetic nephropathy: Collagen staining and renal prognosis.

Koki Mise1, Toshiharu Ueno2, Junichi Hoshino2, Ryo Hazue2, Keiichi Sumida2, Masayuki Yamanouchi2, Noriko Hayami2, Tatsuya Suwabe2, Rikako Hiramatsu3, Eiko Hasegawa3, Naoki Sawa3, Takeshi Fujii4, Shigeko Hara5, Jun Wada6, Hirofumi Makino6, Kenmei Takaichi5, Kenichi Ohashi7, Yoshifumi Ubara5.   

Abstract

AIMS: Nodular lesions are one of the most characteristic pathological changes of advanced diabetic nephropathy (DN). Previous studies have demonstrated that the pattern of both routine and collagen staining of nodular lesions changes during their development. However, the association between such changes of staining and the renal prognosis remains unclear.
METHODS: Among 252 patients with biopsy-proven DN, 67 met the selection criteria and were enrolled to investigate this relationship. In all patients, nodular lesions were stained with periodic acid Schiff, periodic acid methenamine silver, and Masson trichrome stains, and immunostaining was done for type I, III, IV, V, and VI collagen. The endpoint was commencement of dialysis due to end-stage renal disease.
RESULTS: At least one mesangiolytic nodular lesion (MNL) that showed faint staining for PAS and PAM was found in 61% of the patients. MNLs were negative for type IV collagen staining, unlike the strong positivity of non-MNLs, while type V and VI collagen staining were strongly positive in all nodular lesions. Cox proportional hazards regression analysis revealed that the hazard ratio (HR) for the endpoint was significantly higher in patients with at least one MNL than in patients with no MNLs after adjustment for known promoters of renal progression (HR: 2.94; 95% confidence interval: 1.24-7.07).
CONCLUSIONS: MNLs may reflect characteristic differences of collagen production and could be a useful prognostic indicator in patients with nodular lesions. Further investigation of the mechanism underlying these differences of collagen production could contribute to finding new therapeutic targets for DN.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Mesangiolysis; Nodular lesion; Renal pathology; Renal prognosis; Type IV collagen

Mesh:

Substances:

Year:  2017        PMID: 28388509     DOI: 10.1016/j.diabres.2017.03.006

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

1.  Isoflavone Protects the Renal Tissue of Diabetic Ovariectomized Rats via PPARγ.

Authors:  Adriana Aparecida Ferraz Carbonel; Rafael André da Silva; Luiz Philipe de Souza Ferreira; Renata Ramos Vieira; Ricardo Dos Santos Simões; Gisela Rodrigues da Silva Sasso; Manuel de Jesus Simões; José Maria Soares Junior; Patrícia Daniele Azevedo Lima; Fernanda Teixeira Borges
Journal:  Nutrients       Date:  2022-06-21       Impact factor: 6.706

Review 2.  Trajectories of kidney function in diabetes: a clinicopathological update.

Authors:  Megumi Oshima; Miho Shimizu; Masayuki Yamanouchi; Tadashi Toyama; Akinori Hara; Kengo Furuichi; Takashi Wada
Journal:  Nat Rev Nephrol       Date:  2021-08-06       Impact factor: 28.314

3.  Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.

Authors:  Koki Mise; Yutaka Yamaguchi; Junichi Hoshino; Toshiharu Ueno; Akinari Sekine; Keiichi Sumida; Masayuki Yamanouchi; Noriko Hayami; Tatsuya Suwabe; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Takeshi Fujii; Shigeko Hara; Hitoshi Sugiyama; Hirofumi Makino; Jun Wada; Kenichi Ohashi; Kenmei Takaichi; Yoshifumi Ubara
Journal:  PLoS One       Date:  2017-08-15       Impact factor: 3.240

4.  Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy.

Authors:  Kengo Furuichi; Miho Shimizu; Masayuki Yamanouchi; Junichi Hoshino; Norihiko Sakai; Yasunori Iwata; Tadashi Toyama; Shinji Kitajima; Akinori Hara; Yukio Yuzawa; Hiroshi Kitamura; Yoshiki Suzuki; Hiroshi Sato; Noriko Uesugi; Yoshihiko Ueda; Shinichi Nishi; Tomoya Nishino; Kenichi Samejima; Kentaro Kohagura; Yugo Shibagaki; Hirofumi Makino; Seiichi Matsuo; Yoshifumi Ubara; Hitoshi Yokoyama; Takashi Wada
Journal:  BMJ Open Diabetes Res Care       Date:  2020-06

5.  Kidney biopsy guidebook 2020 in Japan.

Authors:  Yoshifumi Ubara; Takehiko Kawaguchi; Tasuku Nagasawa; Kenichiro Miura; Takayuki Katsuno; Takashi Morikawa; Eiji Ishikawa; Masao Ogura; Hideki Matsumura; Ryota Kurayama; Shinsuke Matsumoto; Yuhji Marui; Shigeo Hara; Shoichi Maruyama; Ichiei Narita; Hirokazu Okada; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2021-04       Impact factor: 2.801

6.  Association Between Diabetes and Major Bleeding Complications of Renal Biopsy.

Authors:  Sho Hasegawa; Akira Okada; Shotaro Aso; Ryosuke Kumazawa; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Masaomi Nangaku
Journal:  Kidney Int Rep       Date:  2021-11-25

Review 7.  Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease.

Authors:  María M Adeva-Andany; Natalia Carneiro-Freire
Journal:  World J Diabetes       Date:  2022-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.